While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight ...
Jan 25, 2021
0
2
Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunization against multi-resistant strains is seen ...
Jan 21, 2021
0
3
Healthcare providers must be able to explain the latest data supporting the safety and efficacy of vaccines for coronavirus disease 2019 (COVID-19) so they can strongly encourage vaccination when appropriate while acknowledging ...
Jan 19, 2021
0
3
A vaccine candidate made by China's Sinovac is 78% effective in protecting against COVID-19, according to results of a study announced Thursday by Brazilian state health officials seeking federal approval of the shot.
Jan 07, 2021
0
1
German pharmaceutical firms Bayer and CureVac said Thursday that they have joined forces in the development and supply of CureVac's COVID-19 vaccine candidate.
Jan 07, 2021
0
2
Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...
Jan 06, 2021
2
208
Chinese medics in Shanghai were given COVID-19 inoculations this week, as vaccine makers insisted their jab was effective against current virus mutations.
Jan 05, 2021
0
2
Danish health officials said Monday the country would space out the two doses of the COVID-19 vaccine by up to six weeks, allowing more people to receive a first injection.
Jan 04, 2021
0
12
The European Union is ready to help drug companies expand coronavirus vaccine production to clear a "bottleneck" in distribution, its top health official said Saturday.
Jan 02, 2021
0
5
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results ...
Dec 31, 2020
0
743
